Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ESALY

Recent news which mentions ESALY

< Previous 1 2 3 4 5 Next >
Why Biogen, Lilly, and Prothena Stocks Are Skyrocketing Today
Tickers BIIB ESALY LLY PRTA
Tags ESALY BIIB LLY
From Motley Fool
Why Acumen Pharmaceuticals Stock Is Soaring Today
Tickers ABOS BIIB ESALY
Tags Small Cap BIIB ESALY
From Benzinga
Why Is Cassava Sciences (SAVA) Stock Heating Up Today?
Tickers BIIB ESALY LLY SAVA
Tags NASDAQ:BIIB,NYSE:LLY,NASDAQ:SAVA,OTCMKTS:ESALY Market News Today's Market
From InvestorPlace
Why Is Biogen (BIIB) Stock Up 40% Today?
Tickers BIIB ESALY
Tags Today's Market Market News NASDAQ:BIIB,OTCMKTS:ESALY
From InvestorPlace
Is iPhone Demand Really Slowing Down?, Lyft Freezes Hiring, Biogen's New Drug Slows Alzheimer's Progression: Top Financial Media Stories Wednesday, Sept. 28
Tickers AAPL AMZN BIIB BP
Tags Tech HTZ Government
From Benzinga
What In The World Is Going On With Biogen (BIIB) Shares?
Tickers BIIB ESALY
Tags BIIB ESALY why it's moving
From Benzinga
Why Cassava Sciences Shares Are Soaring Higher
Tickers BIIB ESALY SAVA
Tags SAVA why it's moving BIIB
From Benzinga
Why Biogen Stock Is Up 40% Today
Tickers BIIB ESALY
Tags News BIIB General
From Benzinga
2 Sympathy Plays To Watch For In The Wake Of Biogen's Positive Alzheimer's Drug Data
Tickers BIIB ESALY LLY RHHBY
Tags BIIB News LLY
From Benzinga
US Stock Futures Down Ahead Of Fed Speakers, Economic Data
Tickers AGCO BB BIIB CTAS
Tags Global Market News A Peek Into The Markets
From Benzinga
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
Tickers BIIB ESALY
Tags JP:NIK ESALY BIIB
From MarketWatch
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
Tickers BIIB ESALY
Tags lecanemab FDA Benzinga
From Benzinga
Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer
Tickers ESALF ESALY MRK
Tags News General Briefs
From Benzinga
Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
Tickers ESALF ESALY LLY RHHBF
Tags Benzinga Health Care Biotech
From Benzinga
Here's What Could Make This Beaten-Down Stock a Buy
Tickers BIIB ESALY
Tags ESALY BIIB Recent Press Releases
From Motley Fool
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Tickers ALNY AMRN ARQT BMRN
Tags AMRN MRTX FATE
From Benzinga
Merck's Two Keytruda Combo Cancer Trials Miss Primary Goal
Tickers ESALF ESALY MRK
Tags Market News Large Cap ESALF
From Benzinga
Merck's Oncology Business Will Help It Crush the Bear Market
Tickers AZN ESALY MRK SGEN
Tags Market News AZN Recent Press Releases
From Motley Fool
Is This Biotech Stock a Bad News Buy?
Tickers BIIB ESALY
Tags ESALY BIIB Recent Press Releases
From Motley Fool
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
Tickers AMTI BIIB ESALF ESALY
Tags Market News SRPT RHHBF
From Benzinga
2 Safe Stocks to Buy in a Bear Market
Tickers AZN ESALY ISRG MDT
Tags Market News MRK Recent Press Releases
From Motley Fool
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Tickers AGEN ARWR ATNX AVGR
Tags Earnings ARWR CALA
From Benzinga
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags News BIIB Briefs
From Benzinga
1 Reason to Buy Biogen Now, and 1 Reason to Wait
Tickers BIIB ESALY SAGE
Tags ESALY SAGE BIIB
From Motley Fool
Lilly’s experimental weight-loss drug may be a ‘multibillion-dollar opportunity’
Tickers ESALY LLY PFE SPX
Tags SPX DK:NOVO/B LLY
From MarketWatch
Is This Biotech Stock Worth the Trouble?
Tickers BIIB ESALY LLY SAGE
Tags SAGE Market News ESALY
From Motley Fool
What This Regulatory Approval Could Mean for Merck
Tickers ESALY MRK PFE
Tags PFE ESALY MRK
From Motley Fool
The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study
Tickers ABIO ESALY IBB IMMP
Tags Penny Stocks SLS MRK
From Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
Tickers BIIB ESALF ESALY
Tags Health Care Benzinga Phase 2 Trial
From Benzinga
FDA Approves Second Indication For Merck's Keytruda In Endometrial Cancer
Tickers ESALF ESALY MRK
Tags Biotech ESALY Benzinga
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.